1. |
Lloyd RS, Francois M, Scott G, Malcolm R, Norton G, Fred S, Thomas M, Joseph S, Ed Prokipchuk, Lowell B. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis[J]. Gastroenterology, 1987; 92(35): 1894-1898.
|
2. |
Cobden I, al-Mardini H, Zaitoun A, Record CO. Is topical therapy necessary in acute distal colitis? Double-bind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis[J]. Aliment Pharmacol Ther, 1991; 5(5): 513-522.
|
3. |
Lori K, Hartley C, Cornelius D, Peter R, John Orchard. A comparison of mesalamine suspention enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults[J]. The American Journal of Gastroenterology, 1995; 90(5): 736-739.
|
4. |
Bianchi PG, Ardizzone S, Petrillo M, Fasoli A, Molteni P, Imbesi V. Low pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study[J]. The American Journal of Gastroenterology, 1995; 90(5): 736-739.
|
5. |
Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, Franzin G, Battocchia A, Labo G, Dal MontePR. Treatment of ulcerative colitis with high-dose 5-aminosalicyclic acid enemas[J]. Lancet, 1981; 45(8): 270-271.
|
6. |
Mulder CJ, Tytgat GN, Wiltink EH, Houthoff HJ. Comparison of 5-aminosalicyclic acids and prednisolone phosphate sodium enema in the treatment of distal ulcerative colitis. A prosective, randomized, double-blind trial[J]. Scandinavian Journal of Gastroenterology, 1988; 23(8): 1005-1008.
|
7. |
Gionhetti P, Ardizzine S, Benvenuti ME. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicenter trial[J]. Aliment Phamacol Ther, 1999; 13(3): 381-388.
|
8. |
Danish 5-ASA Group. Topical 5-aminoalicyclic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized double blind multicenter trial[J]. Dig Dis Sci, 1987; 32(6): 598-602.
|
9. |
Campieri M, Gionchetti P, Benizzi A, Brigola C, Tampieri M, Lannone P, Miglioli M, Barbara L. Optimun dosage of 5-aminoalicyclic acid as rectal enemas in patient with active ulcerative colitis[J]. Gut,1991;32(8):929-931.
|
10. |
Sutherland L, Macdonald JK. Oral 5-aminoalicyclic acid for induction of remission in ulcerative colitis(Cochrane Review)[M/CD]. In: The Cochrane Library, Issue 3, 2004. Oxford: Update Software.
|
11. |
Russell DC, Douglas MW, Ronald AT, Thisted, Stephen B, Hanauer. A meta analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis[J]. The American Journal of Gastroenterology, 2000; 95(5): 1263-1276.
|
12. |
Gerassimos JM, Athanassions H, Kalliopi P, Charis S, Georgios T. Intermittent therapy with high-dose 5-aminosalicyclic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis[J]. Dis Colon Rectum, 1994; 37(23): 58-62.
|
13. |
Andreoli A, Spinena S, Levenstein S, Prantera C. 5-aminoalicyclic acid enema versus oral sulphasazine in maintaining remission in ulcerative colitis[J]. Italian Journal of Gastroenterology, 1994; 26(3): 121-125.
|
14. |
Biddle WL, Greenberger NJ, Swan JT, Mcphee MS, Miner PB. 5-aminoalicyclic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis[J]. Gastroenterology, 1988; 94(4): 1075-1079.
|
15. |
Albasio G, Pacini F, Camarri E, Messori A, Trauori G, Bonanomi AG, Bardazzi G, Milla M, Ferrero S, Biaginim, Quaranta S, Amorosi A. Combined therapy with 5-aminoalicyclic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study[J]. American Journal of Gastroenterology, 1997; 92(7): 11143-11147.
|
16. |
Sutherland L, Roth D, Beck P, Makiyama K. Role of 5-aminoalicyclic acid for maintenance of remission in ulcerative colitis(Cochrane Review)[M/CD]. In: The Cochrane Library, Issue 3, 2004. Oxford: Update Software.
|
17. |
Gisbert JP, Gomollon F, Pajares JM. Role of 5-aminoalicyclic acid(5-ASA) in the treatment of inflammatory bowel disease: a systematic review[J]. Digestive Disease and Science, 2002; 47(3): 471-488.
|